We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

GLO:PSEGlobe Telecom Inc. Analysis

Data as of 2026-06-21 - not real-time

$5.99

Latest Price

4/10Risk

Risk Level: Medium

Executive Summary

Clough Global Opportunities Fund (GLO) trades at a trailing P/E of 5.35, far below the industry average of 16.9, and its price‑to‑book ratio of 0.91 suggests a discount to net asset value. The fund delivers an **exceptional dividend yield of 10.76%** with a moderate payout ratio of 53.5%, supported by solid operating cash flow of $27.6 M and positive free cash flow. Technicals show the 20‑day SMA (5.95) sits above the 50‑day (5.90) and 200‑day (5.79) averages, indicating a bullish trend, while the RSI of 54 points to neutral momentum and the MACD histogram is slightly negative, hinting at short‑term caution. The share price of $5.99 remains comfortably above the calculated support at $5.73 and just below the resistance level of $6.10, giving a modest upside cushion. Recent Section 19a filing confirms the latest distribution estimates, reinforcing the fund’s commitment to its high‑yield policy. However, a **debt‑to‑equity ratio of 24.6** and a beta of 0.92 signal modest leverage and slightly lower volatility than the market, respectively. Overall, the combination of deep valuation discounts, strong dividend sustainability, and a stable technical backdrop makes GLO an attractive candidate for income‑focused investors.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 7/10

Key Factors

  • MACD histogram marginally negative indicating near‑term caution
  • Price near support but still above key moving averages
  • Stable trading volume supporting liquidity

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Undervalued valuation metrics (low P/E, P/B)
  • High dividend yield with sustainable payout
  • Bullish SMA alignment confirming trend continuation

Long Term

> 3 years
Positive
Model confidence: 9/10

Key Factors

  • Consistently strong cash flow generation
  • Diversified global asset base reducing geographic concentration
  • Attractive yield and discount to NAV supporting total return

Key Metrics & Analysis

Financial Health

Revenue Growth-18.60%
Profit Margin614.60%
P/E Ratio5.3
ROE17.68%
ROA0.43%
Debt/Equity24.66
P/B Ratio0.9
Op. Cash Flow$27.6M
Free Cash Flow$2.4M
Industry P/E16.9

Technical Analysis

TrendBullish
RSI54.4
Support$5.73
Resistance$6.10
MA 20$5.95
MA 50$5.90
MA 200$5.79
MACDBearish
VolumeStable
Fear & Greed Index91.46

Valuation

GradeUndervalued
TypeValue
Dividend Yield10.76%

Risk Assessment

Beta0.92
Volatility17.18%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.